Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Journal of Central Nervous System Disease|January 8, 2013
Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting InjectionHeidi J Wehring, Sheryl Thedford, Maju Koola, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 12, 2015
The risk of suicide after clozapine discontinuation: Cause for concernKathleen M Patchan, Charles Richardson, Gopal Vyas, et al.Schizophrenia Research|September 19, 2025
Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotypeSonja Xie, Matthew Glassman, Gopal Vyas, et al.Therapeutic Drug Monitoring|June 23, 2020
Comparison of Novel Immunoassay With Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) for Therapeutic Drug Monitoring of ClozapineTiffany Buckley, Christopher Kitchen, Gopal Vyas, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 20, 2021
Feasibility and patient-reported satisfaction using a novel point-of-care fingerstick method for monitoring absolute neutrophil count for clozapineDeanna L Kelly, Olga Y Ponomareva, Marie Mackowick, et al.Journal of Women'S Health (2002)|January 4, 2007
Treatment considerations in women with schizophreniaDeanna L KellyFrontiers in Public Health|July 30, 2026
International advocacy for ketogenic diet research in schizophrenia: insights from a public petitionSidney L Murray, Daniel J O Roche, Christopher M Palmer, et al.The Psychiatric Quarterly|June 24, 2017
Clozapine in Reducing Aggression and Violence in Forensic PopulationsKathleen Patchan, Gopal Vyas, Ann L Hackman, et al.The Journal of Clinical Psychiatry|January 27, 2005
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazineDeanna L Kelly, Robert R ConleyPsychopharmacology Bulletin|February 8, 2007
Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patientsRobert R Conley, Deanna L KellyPageof 18